Editorial policy
01Purpose and independence
This registry exists to organize public material about the nela peptides vendor name and the research-literacy topics its readers search for. It is editorially independent of every vendor, community and platform it describes. Nothing is sold, no sponsorship is accepted, and no affiliate relationship of any kind exists. The vendor directory linked from the footer is an informational index compiled from public material; listing is not an endorsement.
Where the registry has no relationship to declare, it says so; where it has one in the future, it will declare it here first.
02Sourcing standards
Every entry names its evidence tier. Literature claims point to published work through the reference-search blocks at the foot of each page. Public-record references point to regulator indexes and comparable documents. Community claims are attributed to no one: the registry files claim shapes and sample counts, not usernames, and it never quotes private material.
Anonymous material is the weakest tier and is always labeled as such. The registry does not upgrade a claim's tier by repetition, aggregation or phrasing.
03What the registry refuses to publish
No dosing information, no preparation or administration instructions, no human-use guidance of any kind, and no purchasing direction. Entries that reach a sensitive search query answer it with a scope statement and an archive of the phenomenon rather than with instructions. This is a standing editorial rule, not a style preference.
The registry also refuses rankings: no vendor is scored, star-rated or ranked against another, because the underlying material - anonymous, survivorship-biased anecdotes - cannot support such a construction honestly.
04Corrections
Factual corrections are welcome through the contact route on the privacy page. Corrections that change a filed claim type are applied to the entry and noted in its text; corrections of typographical errors are applied silently.